Skip to primary navigation
Skip to main content
Skip to footer

OHF

Oxalosis & Hyperoxaluria Foundation

Facebook
Instagram
Twitter
YouTube
LinkedIn
Get Involved
Donate

Understanding Hyperoxaluria
Living with Hyperoxaluria
- Daily Management
- Hyperoxaluria Awareness Week
Research
Resources
About Us

Home/Visualizer Demo Page

Visualizer Demo Page

Chart by Visualizer

Footer

© 2022 Oxalosis and Hyperoxaluria Foundation. All rights reserved.

Facebook Instagram Twitter YouTube LinkedIn

Cookie Policy Corporate Alliance

Understanding Hyperoxaluria
Living with Hyperoxaluria
Research
- Grants & Funding
Resources
About Us
- Scientific Advisory Board
- Scientific Advisory Council
Get Involved
Donate

News From the OHF

Metabolic Support UK (MSUK) has shared the exciting news that Lumasiran (Oxlumo) has been approved in the UK for those living with PH1. We are grateful to the patients, families, and experts in the field that came together and shared their perspectives on PH!

“We would also like to extend our gratitude to the wonderful team at the [OHF] for their support and assistance in the engagement and insight work required for this appraisal.” —MSUK

International Workshop!